Search

everythinglearnresearchcommunity

for

Search:↓

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Cultural awareness in healthcare improves patient care and relationships.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Intense Pulse Light effectively reduces hair growth in faun tail nevus.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

IPL treatment can significantly reduce hair in faun tail but may need local anesthesia.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Emulgels are promising for delivering drugs topically due to their easy spreadability and stability.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Mutamba fruits are rich in soluble solids, vitamin C, and minerals, making them good for food industry use.

3D imaging effectively tracks skin changes in vitiligo treatment.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Luteolin-loaded nanoformulations could improve cancer treatment by enhancing luteolin's effectiveness.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.